Related Experiment Video
Updated: Nov 11, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
P53 long noncoding RNA regulatory network in cancer development
Surendar Aravindhan1, Laith A Younus2, Methaq Hadi Lafta3
1Department of Pharmacology, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, chennai, India.
Abstract:
The protein p53 as a transcription factor with strong tumor-suppressive activities is known to trigger apoptosis via multiple pathways and is directly involved in the recognition of DNA damage and DNA repair processes. P53 alteration is now recognized as a common event in the pathogenesis of many types of human malignancies. Deregulation of tumor suppressor p53 pathways plays an important role in the activation of cell proliferation or inactivation of apoptotic cell death during carcinogenesis and tumor progression. Mounting evidence indicates that the p53 status of tumors and also the regulatory functions of p53 may be relevant to the long noncoding RNAs (lncRNA)-dependent gene regulation programs. Besides coding genes, lncRNAs that do not encode for proteins are induced or suppressed by p53 transcriptional response and thus control cancer progression. LncRNAs also have emerged as key regulators that impinge on the p53 signaling network orchestrating global gene-expression profile. Studies have suggested that aberrant expression of lncRNAs as a molecular-genomic signature may play important roles in cancer biology. Accordingly, it is important to elucidate the mechanisms by which the crosstalk between lncRNAs and p53 occurs in the development of numerous cancers. Here, we review how several classes of lncRNAs and p53 pathways are linked together in controlling the cell cycle and apoptosis in various cancer cells in both human and mouse model systems.
Insights
The tumor suppressor protein p53 and long noncoding RNAs (lncRNAs) interact to regulate gene expression, impacting cell cycle and apoptosis in cancer. Understanding this crosstalk is crucial for cancer therapy development.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- The protein p53 functions as a transcription factor with significant tumor-suppressive activities, crucial for DNA damage recognition, repair, and apoptosis.
- Alterations in p53 are common in human malignancies, and its pathway deregulation drives carcinogenesis and tumor progression.
- The role of p53 in regulating long noncoding RNAs (lncRNAs) and their impact on cancer biology is increasingly recognized.
Purpose of the Study:
- To review the intricate relationship between p53 pathways and lncRNAs in cancer.
- To elucidate the mechanisms of crosstalk between lncRNAs and p53 in various cancer types.
- To highlight the significance of lncRNA-p53 interactions in controlling cell cycle and apoptosis.
Main Methods:
- Literature review of studies investigating p53 and lncRNA interactions in cancer.
- Analysis of molecular mechanisms linking p53 transcriptional response to lncRNA regulation.
- Examination of lncRNA roles in modulating p53 signaling networks.
Main Results:
- p53 induces or suppresses lncRNAs, which in turn regulate cancer progression.
- lncRNAs act as key regulators within the p53 signaling network, influencing global gene expression.
- Aberrant lncRNA expression serves as a molecular-genomic signature in cancer biology.
Conclusions:
- The crosstalk between lncRNAs and p53 is a critical determinant of cell cycle control and apoptosis in cancer.
- Understanding these interactions is essential for developing novel cancer diagnostics and therapeutics.
- Further research into lncRNA-p53 mechanisms can uncover new therapeutic targets for various cancers.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Negative Regulator Molecules
piRNA - Piwi-interacting RNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

